{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T23:02:39Z","timestamp":1769641359579,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s00059-022-05139-1","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T12:03:40Z","timestamp":1663934620000},"page":"316-324","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Early echocardiographic evaluation of right ventricular load adaptability after sequential combination treatment in pulmonary arterial hypertension","Fr\u00fche echokardiographische Beurteilung der rechtsventrikul\u00e4ren Anpassungsf\u00e4higkeit an die Herzlast nach sequenzieller Kombinationstherapie der pulmonalarteriellen Hypertonie"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1350-215X","authenticated-orcid":false,"given":"Kadriye","family":"Memic Sancar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serkan","family":"Kahraman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Begum","family":"Uygur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umit","family":"Bulut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meltem","family":"Tekin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arda","family":"Guler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nail Guven","family":"Serbest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seda","family":"Tukenmez Karakurt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Banu","family":"Sahin Yildiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet Yasar","family":"Cizgici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammed","family":"Bayram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Erturk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,23]]},"reference":[{"key":"5139_CR1","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"N Galie","year":"2016","unstructured":"Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A et al (2016) 2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 37:67\u2013119. https:\/\/doi.org\/10.1093\/eurheartj\/ehv317","journal-title":"Eur Heart J"},{"key":"5139_CR2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1086\/679699","volume":"5","author":"A Harrison","year":"2015","unstructured":"Harrison A, Hatton N, Ryan JJ (2015) The right ventricle under pressure: evaluating the adaptive and maladaptive changes in the right ventricle in pulmonary arterial hypertension using echocardiography (2013 Grover conference series). Pulm Circ 5:29\u201347. https:\/\/doi.org\/10.1086\/679699","journal-title":"Pulm Circ"},{"key":"5139_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.10.047","author":"AV Noordegraaf","year":"2017","unstructured":"Noordegraaf\u00a0AV, Westerhof\u00a0BE, Westerhof\u00a0N (2017) The relationship between the right ventricle and its load in pulmonary hypertension. J\u00a0Am Coll Cardiol. https:\/\/doi.org\/10.1016\/j.jacc.2016.10.047","journal-title":"J Am Coll Cardiol"},{"key":"5139_CR4","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1378\/chest.14-0793","volume":"146","author":"DB Taichman","year":"2014","unstructured":"Taichman\u00a0DB, Ornelas\u00a0J, Chung\u00a0L, Klinger\u00a0JR, Lewis\u00a0S, Mandel\u00a0J et\u00a0al (2014) Pharmacologic therapy for pulmonary arterial hypertension in adults: CHEST guideline and expert panel report. Chest 146:449\u2013475. https:\/\/doi.org\/10.1378\/chest.14-0793","journal-title":"Chest"},{"key":"5139_CR5","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ijcard.2019.10.043","volume":"301","author":"R Badagliacca","year":"2020","unstructured":"Badagliacca\u00a0R, Papa\u00a0S, Matsubara\u00a0H, Lang\u00a0I, Poscia\u00a0R, Manzi\u00a0G et\u00a0al (2020) The importance of right ventricular evaluation in risk assessment and therapeutic strategies: Raising the bar in pulmonary arterial hypertension. Int J Cardiol 301:183\u2013189. https:\/\/doi.org\/10.1016\/j.ijcard.2019.10.043","journal-title":"Int J Cardiol"},{"issue":"1","key":"5139_CR6","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/bph.14866","volume":"178","author":"K Tello","year":"2021","unstructured":"Tello\u00a0K, Seeger\u00a0W, Naeije\u00a0R, Vanderpool\u00a0R, Ghofrani\u00a0HA, Richter\u00a0M et\u00a0al (2021) Right heart failure in pulmonary hypertension: diagnosis and new perspectives on vascular and direct right ventricular treatment. Br J Pharmacol 178(1):90\u2013107. https:\/\/doi.org\/10.1111\/bph.14866","journal-title":"Br J Pharmacol"},{"issue":"9","key":"5139_CR7","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1164\/rccm.200604-547OC","volume":"174","author":"R Forfia","year":"2006","unstructured":"Forfia\u00a0R, Fisher\u00a0MR, Mathai\u00a0SC, Harris\u00a0TH, Hemnes\u00a0AR, Borlaug\u00a0B et\u00a0al (2006) Tricuspid annular displacement predicts survival in pulmonary hypertension. Am J Respir Crit Care Med 174(9):1034\u20131041. https:\/\/doi.org\/10.1164\/rccm.200604-547OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"5139_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11906-015-0546-0","volume":"17","author":"R Naeije","year":"2015","unstructured":"Naeije\u00a0R (2015) Assessment of right ventricular function in pulmonary hypertension. Curr Hypertens Rep 17(5):35. https:\/\/doi.org\/10.1007\/s11906-015-0546-0","journal-title":"Curr Hypertens Rep"},{"issue":"9","key":"5139_CR9","doi-asserted-by":"publisher","first-page":"H1373","DOI":"10.1152\/ajpheart.00157.2013","volume":"305","author":"M Guazzi","year":"2013","unstructured":"Guazzi\u00a0M, Bandera\u00a0F, Pelissero\u00a0G, Castelvecchio\u00a0S, Menicanti\u00a0L, Ghio\u00a0S et\u00a0al (2013) Tricuspid annular plane systolic excursion and pulmonary arterial systolic pressure relationship in heart failure: An index of right ventricular contractile function and prognosis. Am J Physiol Circ Physiol 305(9):H1373\u2013H1381. https:\/\/doi.org\/10.1152\/ajpheart.00157.2013","journal-title":"Am J Physiol Circ Physiol"},{"key":"5139_CR10","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ijcard.2018.01.053","volume":"266","author":"K Tello","year":"2018","unstructured":"Tello\u00a0K, Axmann\u00a0J, Ghofrani\u00a0HA, Naeije\u00a0R, Narcin\u00a0N, Rieth\u00a0A et\u00a0al (2018) Relevance of the TAPSE\/PASP ratio in pulmonary arterial hypertension. Int J Cardiol 266:229\u2013235. https:\/\/doi.org\/10.1016\/j.ijcard.2018.01.053","journal-title":"Int J Cardiol"},{"issue":"9","key":"5139_CR11","doi-asserted-by":"publisher","first-page":"e009047","DOI":"10.1161\/CIRCIMAGING.119.009047","volume":"12","author":"K Tello","year":"2019","unstructured":"Tello\u00a0K, Wan\u00a0J, Dalmer\u00a0A, Vanderpool\u00a0R, Ghofrani\u00a0HA, Naeije\u00a0R et al (2019) Validation of the tricuspid annular plane systolic excursion\/systolic pulmonary artery pressure ratio for the assessment of right ventricular-arterial coupling in severe pulmonary hypertension. Circ Cardiovasc Imaging 12(9):e9047. https:\/\/doi.org\/10.1161\/CIRCIMAGING.119.009047","journal-title":"Circ Cardiovasc Imaging"},{"issue":"25 Suppl","key":"5139_CR12","doi-asserted-by":"publisher","first-page":"D22","DOI":"10.1016\/j.jacc.2013.10.027","volume":"62","author":"A Vonk-Noordegraaf","year":"2013","unstructured":"Vonk-Noordegraaf\u00a0A, Haddad\u00a0F, Chin\u00a0KM, Forfia\u00a0PR, Kawut\u00a0SM, Lumens\u00a0J et al (2013) Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology. J\u00a0Am Coll Cardiol 62(25 Suppl):D22\u2013D33. https:\/\/doi.org\/10.1016\/j.jacc.2013.10.027","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"5139_CR13","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1097\/MCP.0b013e3283645966","volume":"19","author":"JA Mazurek","year":"2013","unstructured":"Mazurek\u00a0JA, Forfia\u00a0PR (2013) Enhancing the accuracy of echocardiography in the diagnosis of pulmonary arterial hypertension: looking at the heart to learn about the lungs. Curr Opin Pulm Med 19(5):437\u2013445. https:\/\/doi.org\/10.1097\/MCP.0b013e3283645966","journal-title":"Curr Opin Pulm Med"},{"issue":"3","key":"5139_CR14","doi-asserted-by":"publisher","first-page":"G11","DOI":"10.1530\/ERP-17-0071","volume":"5","author":"DX Augustine","year":"2018","unstructured":"Augustine\u00a0DX, Coates-Bradshaw\u00a0LD, Willis\u00a0J, Harkness\u00a0A, Ring\u00a0L, Grapsa\u00a0J et al (2018) Echocardiographic assesment of pulmonary hypertension:a guideline protocol from the British Society of Echocardiography. Echo Res Pract 5(3):G11\u2013G24. https:\/\/doi.org\/10.1530\/ERP-17-0071","journal-title":"Echo Res Pract"},{"issue":"24","key":"5139_CR15","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1016\/j.jacc.2011.06.068","volume":"58","author":"MC Van de Veerdonk","year":"2011","unstructured":"Van de Veerdonk\u00a0MC, Kind\u00a0T, Marcus\u00a0JT, Mauritz\u00a0GJ, Heymans\u00a0MW, Bogaard\u00a0HJ et\u00a0al (2011) Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy. J\u00a0Am Coll Cardiol 58(24):2511\u20132519. https:\/\/doi.org\/10.1016\/j.jacc.2011.06.068","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"5139_CR16","doi-asserted-by":"publisher","first-page":"619","DOI":"10.3390\/jcm10040619","volume":"10","author":"C Miotti","year":"2021","unstructured":"Miotti\u00a0C, Papa\u00a0S, Manzi\u00a0G, Scoccia\u00a0G, Luongo\u00a0F, Toto\u00a0F et\u00a0al (2021) The growing role of echocardiography in pulmonary arterial hypertension risk stratification: The missing piece. J\u00a0Clin Med 10(4):619. https:\/\/doi.org\/10.3390\/jcm10040619","journal-title":"J Clin Med"},{"key":"5139_CR17","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.ijcard.2018.04.053","volume":"266","author":"M Guazzi","year":"2018","unstructured":"Guazzi\u00a0M (2018) Use of TAPSE\/PASP ratio in pulmonary arterial hypertension: an easy shortcut in a\u00a0congested road. Int J Cardiol 266:242\u2013244. https:\/\/doi.org\/10.1016\/j.ijcard.2018.04.053","journal-title":"Int J Cardiol"},{"issue":"1","key":"5139_CR18","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1378\/chest.14-2065","volume":"148","author":"M Guazzi","year":"2015","unstructured":"Guazzi\u00a0M, Naeije\u00a0R, Arena\u00a0R, Corr\u00e0\u00a0U, Ghio\u00a0S, Forfia\u00a0P et\u00a0al (2015) Echocardiography of right ventriculoarterial coupling combined with cardiopulmonary exercise testing to predict outcome in heart failure. Chest 148(1):226\u2013234. https:\/\/doi.org\/10.1378\/chest.14-2065","journal-title":"Chest"},{"key":"5139_CR19","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.chest.2019.09.009","volume":"157","author":"M D\u2019Alto","year":"2020","unstructured":"D\u2019Alto\u00a0M, Badagliacca\u00a0R, Argiento\u00a0P, Romeo\u00a0E, Farro\u00a0A, Papa\u00a0S et\u00a0al (2020) Risk reduction and right heart reverse remodeling by upfront triple combination therapy in pulmonary arterial hypertension. Chest 157:376\u2013383. https:\/\/doi.org\/10.1016\/j.chest.2019.09.009","journal-title":"Chest"},{"key":"5139_CR20","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s00408-018-0160-4","volume":"196","author":"IN Taran","year":"2018","unstructured":"Taran\u00a0IN, Belevskaya\u00a0AA, Saidova\u00a0MA, Martynyuk\u00a0TV, Chazova\u00a0IE (2018) Initial riociguat monotherapy and transition from sildenafil to riociguat in patients with idiopathic pulmonary arterial hypertension: influence on right heart remodeling and right ventricular-pulmonary arterial coupling. Lung 196:745\u2013753. https:\/\/doi.org\/10.1007\/s00408-018-0160-4","journal-title":"Lung"},{"key":"5139_CR21","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cardfail.2019.07.547","volume":"26","author":"AE Huis In\u2019t Veld","year":"2020","unstructured":"Huis In\u2019t Veld\u00a0AE, Oosterveer\u00a0FPT, De Man\u00a0FS, Marcus\u00a0JT, Nossent\u00a0EJ, Boonstra\u00a0A et al (2020) Hemodynamic effects of pulmonary arterial hypertensions pecific therapy in patients with heart failure with preserved ejection fraction and with combined post- and precapillay pulmonary hypertension. J\u00a0Card Fail 26:26\u201334. https:\/\/doi.org\/10.1016\/j.cardfail.2019.07.547","journal-title":"J Card Fail"},{"key":"5139_CR22","doi-asserted-by":"publisher","first-page":"1700007","DOI":"10.1183\/13993003.00007-2017","volume":"49","author":"MC Van de Veerdonk","year":"2017","unstructured":"Van de Veerdonk\u00a0MC, Huis In T Veld\u00a0AE, Marcus\u00a0JT, Westerhof\u00a0N, Heymans\u00a0MW, Bogaard\u00a0HJ et\u00a0al (2017) Upfront combination therapy reduces right ventricular volumes in pulmonary arterial hypertension. Eur Respir\u00a0J 49:1700007. https:\/\/doi.org\/10.1183\/13993003.00007-2017","journal-title":"Eur Respir J"},{"key":"5139_CR23","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1164\/rccm.202004-1006OC","volume":"203","author":"R Badagliacca","year":"2021","unstructured":"Badagliacca\u00a0R, D\u2019Alto\u00a0M, Ghio\u00a0S, Argiento\u00a0P, Bellomo\u00a0V, Brunetti\u00a0ND et\u00a0al (2021) Risk reduction and hemodynamics with initial combination therapy in pulmonary arterial hypertension. Am J Respir Crit Care Med 203:484\u2013492. https:\/\/doi.org\/10.1164\/rccm.202004-1006OC","journal-title":"Am J Respir Crit Care Med"},{"key":"5139_CR24","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1056\/NEJMoa1413687","volume":"373","author":"N Galie","year":"2015","unstructured":"Galie\u00a0N, Barbera\u00a0JA, Frost\u00a0AE, Ghofrani\u00a0HA, Hoeper\u00a0MM, McLaughlin\u00a0VV et\u00a0al (2015) Initial use of ambrisentan plus tadalafil in pulmonary arterial hypertension. N\u00a0Engl J Med 373:834\u2013844. https:\/\/doi.org\/10.1056\/NEJMoa1413687","journal-title":"N Engl J Med"},{"key":"5139_CR25","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1183\/13993003.02043-2015","volume":"47","author":"O Sitbon","year":"2016","unstructured":"Sitbon\u00a0O, Sattler\u00a0C, Bertoletti\u00a0L, Savale\u00a0L, Cottin\u00a0V, Ja\u00efs\u00a0X et\u00a0al (2016) Initial dual oral combination therapy in pulmonary arterial hypertension. Eur Respir\u00a0J 47:1727\u20131736. https:\/\/doi.org\/10.1183\/13993003.02043-2015","journal-title":"Eur Respir J"},{"key":"5139_CR26","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1183\/09031936.00116313","volume":"43","author":"O Sitbon","year":"2014","unstructured":"Sitbon\u00a0O, Ja\u00efs\u00a0X, Savale\u00a0L, Cottin\u00a0V, Bergot\u00a0E, Macari\u00a0EA et\u00a0al (2014) Upfront triple combination therapy in pulmonary arterial hypertension: a\u00a0pilot study. Eur Respir\u00a0J 43:1691\u20131697. https:\/\/doi.org\/10.1183\/09031936.00116313","journal-title":"Eur Respir J"},{"key":"5139_CR27","doi-asserted-by":"publisher","first-page":"2000673","DOI":"10.1183\/13993003.00673-2020","volume":"56","author":"O Sitbon","year":"2020","unstructured":"Sitbon\u00a0O, Cottin\u00a0V, Canuet\u00a0M, Clerson\u00a0P, Gressin\u00a0V, Perchenet\u00a0L et\u00a0al (2020) Initial combination therapy of macitentan and tadalafil in pulmonary arterial hypertension. Eur Respir\u00a0J 56:2000673. https:\/\/doi.org\/10.1183\/13993003.00673-2020","journal-title":"Eur Respir J"},{"key":"5139_CR28","doi-asserted-by":"publisher","first-page":"e000408","DOI":"10.1136\/openhrt-2016-000408","volume":"3","author":"S Ghio","year":"2016","unstructured":"Ghio\u00a0S, Pica\u00a0S, Klersy\u00a0C, Guzzafame\u00a0E, Scelsi\u00a0L, Raineri\u00a0C et\u00a0al (2016) Prognostic value of TAPSE after therapy optimisation in patients with pulmonary arterial hypertension is independent of the haemodynamic effects of therapy. Open Heart 3:e408","journal-title":"Open Heart"},{"key":"5139_CR29","doi-asserted-by":"publisher","first-page":"843606","DOI":"10.3389\/fcvm.2022.843606","volume":"9","author":"WF Lan","year":"2022","unstructured":"Lan\u00a0WF, Deng\u00a0Y, Wei\u00a0B, Huang\u00a0K, Dai\u00a0P, Xie\u00a0SS, Wu\u00a0DD (2022) Echocardiographic evaluation of initial ambrisentan plus phosphodiesterase type 5 inhibitor on right ventricular pulmonary artery coupling in severe pulmonary arterial hypertension patients. Front Cardiovasc Med 9:843606. https:\/\/doi.org\/10.3389\/fcvm.2022.843606","journal-title":"Front Cardiovasc Med"}],"container-title":["Herz"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-022-05139-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00059-022-05139-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-022-05139-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T16:08:17Z","timestamp":1690819697000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00059-022-05139-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,23]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["5139"],"URL":"https:\/\/doi.org\/10.1007\/s00059-022-05139-1","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,23]]},"assertion":[{"value":"5 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"K.M.\u00a0Sancar, M.\u00a0Yildiz, S.\u00a0Kahraman, B.\u00a0Uygur, U.\u00a0Bulut, M.\u00a0Tekin, A.\u00a0Guler, N.\u00a0Guven Serbest, S.T.\u00a0Karakurt, B.S.\u00a0Y\u0131ld\u0131z, A.Y.\u00a0Cizgici, M.\u00a0Bayram and M.\u00a0Erturk declare that they have no competing interests. We wish to confirm that there are no known conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants or on human tissue were in accordance with the ethical standards of the institutional (Ethic Committee of Istanbul Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital with a number of 2021\/26 and date of 23\/03\/2021) and\/or national research committee and with the 1975 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}